Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zosano Pharma

0.5576
0.0000
Volume:- -
Turnover:- -
Market Cap:2.73M
PE:-0.04
High:0.5576
Open:0.5576
Low:0.5576
Close:0.5576
52wk High:37.45
52wk Low:0.4600
Shares:4.90M
Float Shares:4.63M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-15.6859
EPS(LYR):-9.3462
ROE:-192.97%
ROA:-41.86%
PB:0.19
PE(LYR):-0.06

Loading ...

Company Profile

Company Name:
Zosano Pharma
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.